Patent details

Basic Information

Publication number:

EP2726153

PCT Application Number:

US2012045105

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP128040961

PCT Publication Number:

WO2013003808

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

METHODS FOR MODULATING KALLIKREIN (KLKB1) EXPRESSION

French Title of Invention:

PROCÉDÉS DE MODULATION DE L'EXPRESSION DE KALLICRÉINE (KLKB1)

German Title of Invention:

VERFAHREN ZUR MODULIERUNG DER KALLIKREIN (KLKB1)-EXPRESSION

SPC Number:

Dates

Filing date:

29/06/2012

Grant date:

28/03/2018

EP Publication Date:

07/05/2014

PCT Publication Date:

03/01/2013

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

28/03/2018

EP B1 Publication Date:

28/03/2018

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

29/06/2018

Expiration date:

29/06/2032

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

21/03/2018

 

 

Name:

Ionis Pharmaceuticals, Inc.

Address:

2855 Gazelle Court, Carlsbad, CA 92010, United States (US)

Inventor

1

Name:

MACLEOD, Robert, A.

Address:

United States (US)

2

Name:

REVENKO, Alexey

Address:

United States (US)

3

Name:

BHATTACHARJEE, Gourab

Address:

United States (US)

Priority

Priority Number:

201161502739 P

Priority Date:

29/06/2011

Priority Country:

United States (US)

Classification

IPC classification:

A61K 31/712; A61P 7/02; C12N 15/113;

Publication

European Patent Bulletin

Issue number:

201813

Publication date:

28/03/2018

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages
30/10/2018	Outgoing Correspondence	1